Home » Newsletters » BioWorld Science

BioWorld Science

July 26, 2021

View Archived Issues

NKMAX studies SNK-01 with chemotherapy and cetuximab in advanced NSCLC

New phase II trial evaluates BDB-001 for PD-(L)1 refractory solid tumors

Progress in the search for opioid multitarget ligands for persistent pain relief

ECM1a isoform plays a tumorigenic role and confers cancer cell cisplatin resistance

Deep intronic F9 gene variants linked to hemophilia B

Enteric HDL shown to prevent liver injury via portal vein

Targeting TYMP as potential new therapeutic strategy against COVID-19

Sunshine Lake Pharma, Dongguan Hec New Drug Research and Development patent RORgammaT antagonists

Multiple kinase inhibitors identified at Medshine Discovery

New glucagon-like peptide 1 derivatives identified at Gan & Lee Pharmaceuticals

Heterodimeric interference among IKZF family proteins results in inborn errors of immunity

Denali reports interim data from phase I/II study of DNL-310 in Hunter's syndrome

Shionogi initiates phase I trial in Japan of 3CL protease inhibitor S-217622 for COVID-19

Innovent initiates phase Ia study of anti-PD-1/TIGIT bispecific antibody IBI-321

DSMB reviews phase Ib part of ILIAD study of ilixadencel with pembrolizumab in advanced cancers

New mouse model created for cerebral venous sinus thrombosis

Cortexyme selects 3CLpro inhibitor COR-803 to treat coronavirus infections

FDA clears IND for phase I study of NT-I7 for Kaposi sarcoma

MediWound's MW-005 studied in clinical trials for BCC and nonmelanoma skin cancers

Aurion releases preliminary findings from study of cell therapy for corneal endothelial disease

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Dec. 24, 2024.
Today's news in brief
BioWorld MedTech
BioWorld MedTech briefs for December 24, 2024.
Enhanced Cognition: Lewy body dementia phase II pumps stock
BioWorld
Investors will get more details during the International Lewy Body Dementia Conference in Amsterdam late next month, but Wall Street is already buzzing about...
Experimental mRNA gene therapy suppresses preeclampsia in mice
BioWorld MedTech
A gene therapy based on an enhanced lipid nanoparticle (LNP) loaded with vascular endothelial growth factor (VEGF) mRNA could be developed for the treatment of...
Drug duo to Repare lack in gyno cancers? Phase I shows promise
BioWorld
Wall Street wasn’t jumping up and down about Repare Therapeutics Inc.’s early data in gynecological cancers, though the findings look positive and the company has...

BioWorld Premium

Enjoy extended coverage for the most complete market view with BioWorld, BioWorld MedTech, and BioWorld Asia in a single, easy to access subscription.